Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Captor Therapeutics Spolka Akcyjna

Market Cap 488M 130M 114M 105M 98.27M 184M 12.28B 187M 1.26B 6.03B 487M 476M 20.95B P/E 2026 *
25x
P/E 2027 * -295x
Enterprise Value 415M 110M 97M 89.38M 83.67M 157M 10.46B 159M 1.07B 5.13B 415M 406M 17.84B EV / Sales 2026 *
7.33x
EV / Sales 2027 * 8.63x
Free-Float
70.69%
Yield 2026 *
-
Yield 2027 * -
1 day-0.91%
1 week+0.13%
Current month-2.44%
1 month-2.44%
3 months+2.56%
6 months+6.28%
Current year+5.69%
1 week 75
Extreme 75
79
1 month 71
Extreme 71
80
Current year 70.2
Extreme 70.2
89.2
1 year 31.5
Extreme 31.5
89.2
3 years 31.2
Extreme 31.2
155.5
5 years 31.2
Extreme 31.2
209
10 years 31.2
Extreme 31.2
209
Manager TitleAgeSince
Chief Executive Officer 41 2025-05-30
Director of Finance/CFO - 2025-01-31
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Chairman 54 2022-06-29
Director/Board Member 74 2022-06-29
Director/Board Member - 2022-06-29
Date Insider Type Main position Quantity % Market Cap.
02-25Buy 1,100 0.0198%
12-11Free

Chairman

360,074 6.5128%
12-11Free

Chairman

360,074 6.5128%
Change 5-day change 1-year change 3-year change Capi.($)
-0.91%+0.13%+136.34%-50.90% 130M
+3.20%+7.56%-6.91%+1.69% 44.45B
-0.20%+7.13%+322.22%+579.59% 36.04B
+1.42%+5.83%+4.20%+54.37% 30.7B
+7.76%+6.80%+14.94%-14.75% 28.59B
-4.75%-8.02%+5.99%+12.28% 23.01B
+1.06%+4.30% - - 14.82B
+6.26%+8.97%+57.98%+121.26% 13.52B
+3.22%+7.64%+11.56%+19.99% 12.98B
+2.38%+3.68%+94.36%+97.05% 12.56B
Average +1.94%+1.73%+71.19%+91.17% 21.68B
Weighted average by Cap. +2.13%+2.30%+69.99%+126.77%

Financials

2026 *2027 *
Net sales 56.7M 15.07M 13.24M 12.2M 11.42M 21.4M 1.43B 21.76M 146M 700M 56.57M 55.35M 2.43B 48.5M 12.89M 11.32M 10.43M 9.77M 18.3M 1.22B 18.61M 125M 599M 48.39M 47.35M 2.08B
Net income -3M -797K -700K -645K -604K -1.13M -75.53M -1.15M -7.75M -37.06M -2.99M -2.93M -129M -1.5M -399K -350K -323K -302K -566K -37.77M -576K -3.88M -18.53M -1.5M -1.46M -64.4M
Net Debt -72.5M -19.27M -16.93M -15.6M -14.6M -27.36M -1.83B -27.82M -187M -896M -72.34M -70.78M -3.11B -69.5M -18.47M -16.23M -14.95M -14M -26.23M -1.75B -26.67M -180M -859M -69.34M -67.85M -2.98B
Logo Captor Therapeutics Spolka Akcyjna
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
Employees
82
Date Price Change Volume
26-06-24 PLN 76.10 -0.91% 541
26-06-23 PLN 76.80 -0.90% 2,271
26-06-22 PLN 77.50 -1.90% 480
26-06-19 PLN 79.00 +3.27% 4,630
26-06-18 PLN 76.50 +0.66% 603
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
76.80PLN
Average target price
86.83PLN
Spread / Average Target
+13.06%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!